The BATTLE Trial: A Bold Step toward Improving the Efficiency of Biomarker-Based Drug Development

Successful completion of the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial, reported in this issue of Cancer Discovery, is an important advance in the effort to improve clinical trial approaches to the simultaneous development of new therapeutics with matching diagnostic tests so that patients most likely to benefit from these therapies can be identified. Cancer Discovery; 1(1); 17-20. (C) 2011 AACR.